About this FactMed analysis covering adverse side effect reports of AIRBORNE patients who developed INFLUENZA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking AIRBORNE reported INFLUENZA to the FDA. A total of 20 AIRBORNE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AIRBORNE and INFLUENZA. In doing so, we compare AIRBORNE with other drugs that cause INFLUENZA, to help you evaluate whether or not AIRBORNE causes INFLUENZA. Likewise, this page shows the most highly-reported side effects of AIRBORNE, so you can see if INFLUENZA ranks among AIRBORNE's most well-known side effects.
Summary Statistics
Reports of AIRBORNE causing INFLUENZA: 3
Reports of any side effect of AIRBORNE : 20
Percentage of AIRBORNE patients where INFLUENZA is a reported side effect: 15.0000%

FDA reports of any drug causing INFLUENZA : 14304
Average percentage for all medicated patients where INFLUENZA is reported as a complication: 0.0896%

Physician opinion on AIRBORNE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AIRBORNE:
MEDICAL DIET ( 3 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 1 patients )
NASOPHARYNGITIS ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with INFLUENZA:

HUMIRA (1533 patients)
ENBREL (1384 patients)
TYSABRI (1101 patients)
AVONEX (988 patients)
FOSAMAX (967 patients)
SEROQUEL (762 patients)
ASPIRIN (748 patients)
METHOTREXATE (664 patients)
XOLAIR (621 patients)
FORTEO (604 patients)
NEXIUM (587 patients)
VIOXX (585 patients)
PREDNISONE (582 patients)
FOLIC ACID (494 patients)
PAXIL (483 patients)
LIPITOR (451 patients)
REMICADE (443 patients)
SYNTHROID (367 patients)
REVLIMID (354 patients)
PREDNISOLONE (352 patients)
SANDOSTATIN LAR (342 patients)
EXJADE (332 patients)
BYETTA (331 patients)
SOLIRIS (328 patients)
REBIF (324 patients)
CHANTIX (311 patients)
PRILOSEC (308 patients)
OMEPRAZOLE (298 patients)
LISINOPRIL (290 patients)
LYRICA (282 patients)
NEURONTIN (281 patients)
LASIX (280 patients)
HYDROCHLOROTHIAZIDE (276 patients)
VITAMIN D (274 patients)
DIOVAN (270 patients)
DIAZEPAM (264 patients)
CRESTOR (263 patients)
CYMBALTA (258 patients)
ALBUTEROL (257 patients)
PLAVIX (256 patients)
XANAX (251 patients)
COUMADIN (251 patients)
ACETAMINOPHEN (249 patients)
SINGULAIR (248 patients)
CALCIUM (244 patients)
ADVAIR DISKUS 100/50 (242 patients)
PREDNISONE TAB (242 patients)
ZOLOFT (240 patients)
ZOMETA (239 patients)
NORVASC (238 patients)
ATENOLOL (237 patients)
LEVOTHYROXINE SODIUM (233 patients)
PREVACID (231 patients)
ZOCOR (221 patients)
TAMIFLU (219 patients)
LEVAQUIN (213 patients)
SIMVASTATIN (210 patients)
METFORMIN HCL (208 patients)
GABAPENTIN (207 patients)
CLONAZEPAM (200 patients)
TOPROL-XL (198 patients)
LORAZEPAM (194 patients)
IBUPROFEN (191 patients)
FUROSEMIDE (189 patients)
SYNAGIS (185 patients)
CELEBREX (184 patients)
FORASEQ (184 patients)
VICODIN (178 patients)
CELEXA (177 patients)
ACTEMRA (176 patients)
ACCUTANE (175 patients)
PROTONIX (172 patients)
SYMBICORT (171 patients)
POTASSIUM CHLORIDE (170 patients)
AMBIEN (169 patients)
CLOZARIL (167 patients)
DEXAMETHASONE (160 patients)
ALPRAZOLAM (159 patients)
OMALIZUMAB (158 patients)
BETASERON (157 patients)
EFFEXOR (154 patients)
LANTUS (154 patients)
SPIRIVA (150 patients)
PROZAC (146 patients)
LEXAPRO (146 patients)
KLONOPIN (145 patients)
ALLI (144 patients)
OXYCONTIN (140 patients)
FLEXERIL (140 patients)
BONIVA (140 patients)
SUBOXONE (138 patients)
ZOFRAN (137 patients)
RIBAVIRIN (133 patients)
METOPROLOL TARTRATE (133 patients)
CALCIUM CARBONATE (133 patients)
VENTOLIN (133 patients)
PEG-INTRON (132 patients)
ATIVAN (131 patients)
RECLAST (131 patients)
VITAMIN B-12 (131 patients)
PREMARIN (130 patients)
CIMZIA (128 patients)
ZYRTEC (127 patients)
RANITIDINE (126 patients)
AREDIA (122 patients)
PERCOCET (122 patients)
ZOLEDRONOC ACID (121 patients)
BACLOFEN (120 patients)
ALDACTONE (118 patients)
EXTAVIA (116 patients)
LAMICTAL (116 patients)
MULTI-VITAMINS (116 patients)
VALIUM (116 patients)
FAMOTIDINE (115 patients)
WELLBUTRIN (115 patients)
TYLENOL (CAPLET) (114 patients)
PAROXETINE HCL (113 patients)
OXYCODONE HCL (111 patients)
AMITRIPTYLINE HCL (111 patients)
ACTONEL (108 patients)
VELCADE (107 patients)
ALLEGRA (107 patients)
BENADRYL (106 patients)
ZANTAC (106 patients)
FENTANYL (104 patients)
WARFARIN SODIUM (104 patients)
FISH OIL (103 patients)
DURAGESIC-100 (103 patients)
CITALOPRAM HYDROBROMIDE (102 patients)
AMLODIPINE (101 patients)
DIGOXIN (100 patients)
GLUCOPHAGE (100 patients)
ZITHROMAX (98 patients)
TRAZODONE HCL (98 patients)
VERAPAMIL (97 patients)
HUMALOG (96 patients)
[THERAPY UNSPECIFIED] (95 patients)
BACTRIM (94 patients)
LORTAB (94 patients)
PRAVACHOL (94 patients)
ENALAPRIL MALEATE (93 patients)
MULTI-VITAMIN (93 patients)
FLONASE (92 patients)
INSULIN (90 patients)
PROPRANOLOL (90 patients)
METFORMIN (90 patients)
SOMA (89 patients)
NIASPAN (89 patients)
FORMOTEROL FUMARATE (89 patients)
RISPERDAL (89 patients)
TYLENOL (89 patients)
GLIPIZIDE (89 patients)
MORPHINE (88 patients)
ASCORBIC ACID (88 patients)
PROGRAF (88 patients)
CLOZAPINE (88 patients)
ALLOPURINOL (88 patients)
VITAMIN E (87 patients)
STRATTERA (87 patients)
TRAMADOL HCL (86 patients)
TRACLEER (86 patients)
FEMARA (85 patients)
NAPROXEN (85 patients)
DIANEAL (85 patients)
DILANTIN (84 patients)
CLARITHROMYCIN (84 patients)
TOPAMAX (83 patients)
COZAAR (83 patients)
ZYPREXA (83 patients)
NITROGLYCERIN (82 patients)
METOPROLOL (82 patients)
AMOXICILLIN (82 patients)
CAPTOPRIL (81 patients)
CYCLOPHOSPHAMIDE (81 patients)
PLAQUENIL (80 patients)
MEDROL (80 patients)
EFFEXOR XR (80 patients)
DECADRON (79 patients)
CLINDAMYCIN (79 patients)
ACTOS (79 patients)
TEGRETOL (79 patients)
ALENDRONATE SODIUM (77 patients)
THALIDOMIDE (76 patients)
FLUOXETINE (76 patients)
DIOVAN HCT (76 patients)
COREG (76 patients)
CLARITIN (75 patients)
PEGASYS (74 patients)
RITUXIMAB (73 patients)
HYDROCODONE (73 patients)
VALTREX (73 patients)
SPIRONOLACTONE (72 patients)
ARAVA (72 patients)
CYCLOSPORINE (72 patients)
PANTOPRAZOLE (71 patients)
PARACETAMOL (71 patients)
LOPRESSOR (70 patients)
METHADONE HCL (70 patients)
NUVARING (69 patients)
HYDROCODONE BITARTRATE (69 patients)
PROMETHAZINE (69 patients)
GOLIMUMAB (69 patients)
FERROUS SULFATE TAB (69 patients)
VITAMINS (68 patients)
EVISTA (68 patients)
CHEMOTHERAPEUTICS NOS (68 patients)
ZETIA (68 patients)
GILENYA (68 patients)
REBETOL (67 patients)
AMARYL (67 patients)
Most common side effects for patients taking AIRBORNE:
ALOPECIA (4 patients)
CONFUSIONAL STATE (4 patients)
AGEUSIA (3 patients)
ARTHRALGIA (3 patients)
LIGAMENT OPERATION (3 patients)
INFLUENZA (3 patients)
DRUG EFFECT DECREASED (3 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (2 patients)
VISION BLURRED (2 patients)
RESTLESSNESS (2 patients)
NASOPHARYNGITIS (2 patients)
MULTIPLE MYELOMA (2 patients)
CEREBROVASCULAR ACCIDENT (2 patients)
COORDINATION ABNORMAL (2 patients)
DRUG INEFFECTIVE (2 patients)
HYPOAESTHESIA (2 patients)
EPISTAXIS (2 patients)
DYSGRAPHIA (2 patients)
DYSARTHRIA (2 patients)
DRY SKIN (1 patients)
DYSPHEMIA (1 patients)
ECZEMA WEEPING (1 patients)
DRY MOUTH (1 patients)
ERYTHEMA (1 patients)
FATIGUE (1 patients)
FEELING ABNORMAL (1 patients)
GENITAL PAIN (1 patients)
HEADACHE (1 patients)
HEARING IMPAIRED (1 patients)
HEART RATE DECREASED (1 patients)
HYPERKERATOSIS (1 patients)
DRY EYE (1 patients)
HYPOREFLEXIA (1 patients)
CONSTIPATION (1 patients)
INJECTION SITE ERYTHEMA (1 patients)
INJECTION SITE IRRITATION (1 patients)
INJECTION SITE SWELLING (1 patients)
INSOMNIA (1 patients)
INTERNATIONAL NORMALISED RATIO ABNORMAL (1 patients)
LEARNING DISORDER (1 patients)
CONDITION AGGRAVATED (1 patients)
LIP SWELLING (1 patients)
LOCALISED INFECTION (1 patients)
LUNG NEOPLASM MALIGNANT (1 patients)
MEMORY IMPAIRMENT (1 patients)
APHASIA (1 patients)
ANXIETY (1 patients)
NAUSEA (1 patients)
NEOPLASM MALIGNANT (1 patients)
PRURITUS (1 patients)
PYREXIA (1 patients)
RASH (1 patients)
AMNESIA (1 patients)
RHINORRHOEA (1 patients)
SOMNOLENCE (1 patients)
SYNCOPE (1 patients)
URTICARIA (1 patients)
ACUTE SINUSITIS (1 patients)
WEIGHT INCREASED (1 patients)
WITHDRAWAL SYNDROME (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AIRBORNE


Issue Description / Topic Timestamp
CONCERN
DRY MOUTH
Took last night have severe dry mouth 2015-11-18 06:01:39
QUESTION
INSOMNIA
I take Amitryptyline and Trazodone. When I use Airborne I cannot get to sleep. 2017-10-07 15:22:45

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about INFLUENZA and AIRBORNE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AIRBORNE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AIRBORNE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AIRBORNE experts. If you are a healthcare provider experienced in prescribing AIRBORNE, please register here.

Your online appointment book for Groton Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use